Global Kaposi Sarcoma Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431681
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Aphios Corp.
  • Cytori Therapeutics, Inc.
  • CytRx Corporation
  • Eli Lilly and Co.
  • F.Hoffman La-Roche, Inc.
  • GlaxoSmithKline plc.
  • MORE
Kaposi Sarcoma Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global kaposi sarcoma market was valued at US$ 108.8 Mn in 2016, and is expected to reach US$ 135.6 Mn by 2025 expanding at a CAGR of 2.44% from 2017 to 2025.

Market Insights

Kaposi sarcoma has an incidence rate of 0.02-0.06%, it is widely prevalent in middle aged Afro-American men, East-European and Mediterranean region men of Jewish origin (Ashkenazi). Kaposi sarcoma has overwhelming male predominance. Serological assays for the detection of Kaposi sarcoma are limited and has often resulted in the production of conflicted data with different methodologies. Polymerase chain reaction, insitu hybridization, and immunohistochemistry reveal the KSHV proteins expressed in the human tissue.

In 2016, HAART (highly active antiretroviral therapy) segment dominated the market due to rising prevalence of AIDS, as patients suffering with HIV infection are 20,000 times prone to develop Kaposi sarcoma and the proactive government initiative such as United States Presidents Emergency Plan for AIDS Relief (PEPFAR) to fight AIDS-KS. Chemotherapy will be the fastest growing segment throughout the forecast period 2017-2025 majorly due to factors such as technological advancement in the drug formulation for e.g. paclitaxel nanosomal formulation utilized as a topical treatment for AIDS-KS surpassing the drug biotransformation which is toxic to liver cells. Promising pipeline with excellent bioequivalence studies such as AT-0918 (Cytori Therapeutics, Inc.). Aldoxorubicin (CytRx Corporation) utilizes acid sensitive linker that selectively binds to albumin to allow the cytotoxic payload to accumulate near the tumor and spare the surrounding healthy tissues.

In 2016, North America held the largest revenue share mainly due to factors such as rising prevalence of Kaposi sarcoma, presence of pharmaceutical giants primarily focusing on Kaposi sarcoma treatment and presence of developed research and healthcare institutions. Asia Pacific will be the fastest growing market throughout the forecast period 2017-2025, majorly due to increasing disposable incomes in these regions and supportive regulatory environment for Kaposi sarcoma drugs.

Key Market Movements:
  • Rising prevalence of AIDS-KS
  • Technological advancement has led to improvement in the drug formulation such as targeted immunotherapy and nanosomes to avoid cytotoxicity to healthy cells
  • Supportive regulatory environment for Kaposi sarcoma drugs
  • Affordable reimbursement scenario for the treatment of Kaposi sarcoma in developed countries
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aphios Corp.
  • Cytori Therapeutics, Inc.
  • CytRx Corporation
  • Eli Lilly and Co.
  • F.Hoffman La-Roche, Inc.
  • GlaxoSmithKline plc.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Kaposi Sarcoma Market Portraiture
2.1.1. Global Kaposi Sarcoma Market, by Treatment Type, 2016
2.1.2. Global Kaposi Sarcoma Market, by Geography, 2016

Chapter 3. Kaposi Sarcoma: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Kaposi Sarcoma Market, by Treatment Type
4.3. Chemotherapy
4.3.1. Alkaloids
4.3.2. Liposomal Anthracyclines
4.4. Immunotherapy
4.5. Highly Active Antiretroviral Therapy (HAART)
4.6. Radiation Therapy
4.7. Surgical Procedures

Chapter 5. Global Kaposi Sarcoma Market, by Geography, 2015 - 2025 (US$ Mn)
5.1. Overview
5.2. North America Kaposi Sarcoma Market Analysis, 2015 - 2025
5.2.1. North America Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
5.2.2. North America Kaposi Sarcoma Market, by Country, 2015 - 2025 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Kaposi Sarcoma Market Analysis, 2015 - 2025
5.3.1. Europe Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
5.3.2. Europe Kaposi Sarcoma Market, by Country, 2015 - 2025 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. France
5.3.2.4. Rest of Europe
5.4. Asia Pacific Kaposi Sarcoma Market Analysis, 2015 - 2025
5.4.1. Asia Pacific Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
5.4.2. Asia Pacific Kaposi Sarcoma Market, by Country, 2015 - 2025 (US$ Mn)
5.4.2.1. Japan
5.4.2.2. China
5.4.2.3. India
5.4.2.4. Rest of APAC
5.5. Latin America Kaposi Sarcoma Market Analysis, 2015 - 2025
5.5.1. Latin America Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
5.5.2. Latin America Kaposi Sarcoma Market, by Country, 2015 - 2025 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Kaposi Sarcoma Market Analysis, 2015 - 2025
5.6.1. MEA Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
5.6.2. MEA Kaposi Sarcoma Market, by Region, 2015 - 2025 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Aphios Corp.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Bristol Myers Squibb Company
6.3. Cytori Therapeutics, Inc.
6.4. CytRx Corporation
6.5. Eli Lilly and Co.
6.6. GlaxoSmithKline plc.
6.7. F.Hoffman La-Roche, Inc.
6.8. Johnson and Johnson
6.9. Merck & Co., Inc.
6.10. Pfizer, Inc.
6.11. Other Notable Players

List of Figures
Fig. 1 Kaposi Sarcoma: Market Segmentation
Fig. 2 Global Kaposi Sarcoma Market Share, by Treatment Type, 2016 (Value %)
Fig. 3 Global Kaposi Sarcoma Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition, by Geography
Fig. 5 Market Competition Landscape, by Key Players, 2016
Fig. 6 Global Chemotherapy Market, 2015 - 2025 (US$ Mn)
Fig. 7 Global Alkaloids Market, 2015 - 2025 (US$ Mn)
Fig. 8 Global Liposomal Anthracyclines Market, 2015 - 2025 (US$ Mn)
Fig. 9 Global Immunotherapy Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global HAART Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Radiation Therapy Market, 2015 - 2025 (US$ Mn)
Fig. 12 Global Surgical Procedures Market, 2015 - 2025 (US$ Mn)
Fig. 13 U.S. Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 14 Canada Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 15 U.K. Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 16 Germany Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 17 France Kaposi Sarcoma Market, 2015-2025 (US$ Mn)
Fig. 18 Rest of Europe Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 19 Japan Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 20 China Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 21 India Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 22 Rest of Asia Pacific Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 23 Brazil Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 24 Mexico Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 25 Rest of Latin America Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 26 GCC Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)
Fig. 27 Rest of Middle East and Africa Kaposi Sarcoma Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
Table 2 Global Kaposi Sarcoma Market, by Geography, 2015 - 2025 (US$ Mn)
Table 3 North America Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
Table 4 North America Kaposi Sarcoma Market, by Country, 2015 - 2025 (US$ Mn)
Table 5 Europe Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
Table 6 Mn)
Table 7 Europe Kaposi Sarcoma Market, by Country, 2015 - 2025 (US$ Mn)
Table 8 Asia Pacific Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
Table 9 Asia Pacific Kaposi Sarcoma Market, by Country, 2015 - 2025 (US$ Mn)
Table 10 Latin America Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
Table 11 Latin America Kaposi Sarcoma Market, by Country, 2015 - 2025 (US$ Mn)
Table 12 Middle East and Africa Kaposi Sarcoma Market, by Treatment Type, 2015 - 2025 (US$ Mn)
Table 13 Middle East and Africa Kaposi Sarcoma Market, by Region, 2015 - 2025 (US$ Mn)
Table 14 Aphios Corp.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 15 Bristol Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 16 Cytori Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 17 CytRx Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 18 Eli Lilly and Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 19 GlaxoSmithKline plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 20 F.Hoffman La-Roche, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 21 Johnson and Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 22 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 23 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aphios Corp.
  • Bristol Myers Squibb Company
  • Cytori Therapeutics, Inc.
  • CytRx Corporation
  • Eli Lilly and Co.
  • GlaxoSmithKline plc.
  • F.Hoffman La-Roche, Inc.
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Other Notable Players
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll